Understanding PTSD Takes On Urgency

Thousands of cases of post-traumatic stress disorder (PTSD) will likely emerge from the Sept. 11 terrorist attacks. Many cases will last a few months, but severely traumatized witnesses could suffer for the rest of their lives. How can a single horrific experience with nasty aftershocks sear the psyche for decades? Answers to this question appear increasingly urgent in an atmosphere of war, anthrax scares, and continual television replays of the World Trade Center collapse. Researchers have lin

Written byDouglas Steinberg
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Researchers have linked PTSD to changes in the brain and body. But association is not causation, and biologists hotly contest the significance of these changes. Inconsistent findings fuel the debate, and the ethical limitations of psychiatric research, combined with a lack of animal models, might make some issues impossible to resolve. The stakes in these scientific disputes are high: greater consensus could channel resources into better prevention and treatment strategies.

"When a field has a lot of controversies, it means to me that there are a lot of missing pieces of a puzzle," observes Rachel Yehuda, director of the traumatic stress studies division of New York's Mount Sinai School of Medicine. The terrorist attacks might spur discovery of some of those pieces: PTSD researchers are already submitting grant applications related to the disaster. Steven E. Hyman, director of the National Institute of Mental Health (NIMH), where many of these submissions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies